Cas No.: 500577-51-5
PRODUCT INFORMATION
Description
Cyclo(-RGDfK) (Cyclo[Arg-Gly-Asp-D-Phe-Lys]) is a potent (IC50 = 0.94 nM) and selective inhibitor of the αvβ3 integrin. It is known to effectively bind to both tumor microvasculature and cancer cell lines in vitro by specifically interacting with cell-surface αvβ3 integrin. It is a foundational tool for research into integrin-mediated signaling and adhesion.
Molecular Weight
717.69
Purity
> 95%
Formula
C₂₉H₄₂F₃N₉O₉
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Lys]
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- F3 Targeting Peptide (CAT#: OLY-1025-YS-28)
- Tyr-Somatostatin-14 Targeting Peptide (CAT#: OLY-1025-YS-63)
- IRGD Peptide 1 TFA (CAT#: OLY-1025-YS-58)
- Cys-SP94 Targeting Peptide (CAT#: OLY-1025-YS-35)
- T9 Targeting Peptide (CAT#: OLY-1025-YS-19)
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- Cyclo(RADfK) Targeting Peptide (CAT#: OLY-1025-YS-61)
- Aminopeptidase N Ligand (CD13) NGR Targeting Peptide (CAT#: OLY-1025-YS-10)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.